Literature DB >> 29556768

Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAFV600E mutation.

Moozhan Nikpanah1, Lauren Kim1, S Mojdeh Mirmomen1, Rolf Symons1, Ioannis Papageorgiou2, William A Gahl3, Kevin O'Brien3, Juvianee I Estrada-Veras3, Ashkan A Malayeri4.   

Abstract

OBJECTIVES: To use magnetic resonance imaging (MRI) and computed tomography (CT) to define abdominal involvement in Erdheim-Chester disease (ECD), and to investigate the association between these findings and the BRAFV600E mutation.
METHODS: This prospective study was performed on 61 ECD patients (46 men). The MRI and CT imaging studies were reviewed independently by two experienced radiologists. The association between BRAFV600E mutation and imaging findings was analysed using Fisher's exact test, and odds ratios with 95% confidence intervals.
RESULTS: Perinephric infiltration was the most common finding (67%), followed by involvement of proximal ureters (61%). In 56% of cases, infiltration extended to the renal sinuses, and in 38% caused hydronephrosis. Adrenal gland infiltration was present in 48% of patients. Infiltration of renal artery (49%) and aorta (43%) were the most common vascular findings, followed by sheathing of celiac, superior mesenteric artery (SMA) or inferior mesenteric artery (IMA) (23%). The BRAFV600E mutation was positive in 53% of patients with interpretable BRAF sequencing. There was a statistically significant association between this mutation and perinephric infiltration (p = 0.003), renal sinus involvement (p < 0.001), infiltration of proximal ureters (p < 0.001), hydronephrosis (p < 0.001), adrenal gland involvement (p < 0.001), periaortic infiltration (p = 0.03), sheathing or stenosis of renal artery (p < 0.001) and sheathing of other aortic branches (p = 0.04).
CONCLUSIONS: Renal and vascular structures are the most commonly affected abdominal organs in ECD patients. Some of these findings have significant positive association with the BRAFV600E mutation. KEY POINTS: • Abdominal imaging plays a crucial role in management of Erdheim-Chester disease. • Significant associations exist between BRAF V600E mutation and several abdominal imaging findings. • Considering several associations, evaluating BRAFV600E mutation status is recommended in ECD patients.

Entities:  

Keywords:  Abdomen; Erdheim–Chester disease; Magnetic resonance imaging; Multidetector computed tomography; Proto-oncogene proteins B-Raf

Mesh:

Substances:

Year:  2018        PMID: 29556768     DOI: 10.1007/s00330-018-5326-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  37 in total

Review 1.  Erdheim-Chester disease.

Authors:  Julien Haroche; Laurent Arnaud; Zahir Amoura
Journal:  Curr Opin Rheumatol       Date:  2012-01       Impact factor: 5.006

2.  Imaging of thoracoabdominal involvement in Erdheim-Chester disease.

Authors:  Elisabeth Dion; Claire Graef; Julien Haroche; Raphaële Renard-Penna; Philippe Cluzel; Bertrand Wechsler; Jean-Charles Piette; Philippe A Grenier
Journal:  AJR Am J Roentgenol       Date:  2004-11       Impact factor: 3.959

3.  Spectrum of abdominal imaging findings in histiocytic disorders.

Authors:  Natally de Souza Maciel Rocha Horvat; Clovis Rego Coelho; Larissa Cardoso Roza; Rodrigo Canellas de Souza; Yves Bohrer Costa; Ebe Christie de Oliveira; Manoel de Souza Rocha; Ronaldo Hueb Baroni
Journal:  Abdom Imaging       Date:  2015-10

4.  BRAF mutations in Erdheim-Chester disease.

Authors:  Jean-François Emile; Frédéric Charlotte; Zahir Amoura; Julien Haroche
Journal:  J Clin Oncol       Date:  2012-12-17       Impact factor: 44.544

5.  Vemurafenib (BRAF Inhibitor) Therapy for Orbital Erdheim-Chester Disease.

Authors:  Adit Gupta; Amir Yeganeh; Daniel Rootman; Robert Goldberg
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2017 Nov/Dec       Impact factor: 1.746

Review 6.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

7.  Urologic manifestations of Erdheim-Chester disease.

Authors:  Daniel A Yelfimov; Deborah J Lightner; Matthew K Tollefson
Journal:  Urology       Date:  2014-04-27       Impact factor: 2.649

Review 8.  Erdheim-Chester disease.

Authors:  Corrado Campochiaro; Alessandro Tomelleri; Giulio Cavalli; Alvise Berti; Lorenzo Dagna
Journal:  Eur J Intern Med       Date:  2015-04-10       Impact factor: 4.487

Review 9.  Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review.

Authors:  Julien Haroche; Zahir Amoura; Elisabeth Dion; Bertrand Wechsler; Nathalie Costedoat-Chalumeau; Patrice Cacoub; Richard Isnard; Thierry Généreau; Janine Wechsler; Nina Weber; Claire Graef; Philippe Cluzel; Philippe Grenier; Jean-Charles Piette
Journal:  Medicine (Baltimore)       Date:  2004-11       Impact factor: 1.889

10.  Perinephric xanthogranulomatosis: CT diagnosis and confirmation by CT-guided percutaneous biopsy.

Authors:  M Scheer; M Hon; A A Fruauff; W Blumenfeld; Z D Grossman; D S Katz
Journal:  Clin Imaging       Date:  2000 Mar-Apr       Impact factor: 1.605

View more
  5 in total

1.  Thoracic involvement in Erdheim-Chester disease: computed tomography imaging findings and their association with the BRAFV600E mutation.

Authors:  S Mojdeh Mirmomen; Arlene Sirajuddin; Moozhan Nikpanah; Rolf Symons; Anna K Paschall; Ioannis Papageorgiou; William A Gahl; Kevin O'Brien; Juvianee I Estrada-Veras; Ashkan A Malayeri
Journal:  Eur Radiol       Date:  2018-05-07       Impact factor: 5.315

Review 2.  Imaging of Histiocytosis in the Era of Genomic Medicine.

Authors:  Hyesun Park; Mizuki Nishino; Jason L Hornick; Eric D Jacobsen
Journal:  Radiographics       Date:  2018-11-30       Impact factor: 5.333

3.  Urinary involvement in Erdheim-Chester disease: computed tomography imaging findings.

Authors:  Zhe Wu; Guo-Lu Jiang; Yi Tang; Chao Jiang; Lu-Lu Sun; Ning Li; Zheng-Yu Jin; Hao Sun
Journal:  Abdom Radiol (NY)       Date:  2021-05-10

4.  Erdheim-Chester Disease With Concurrent Lung Adenocarcinoma.

Authors:  Nadia Solomon; Arne Landwehr; Zerwa Farooq; Garfield Gutzmore; Horace Tang; Sandeep Singh Tuli; Vincent Rizzo
Journal:  J Investig Med High Impact Case Rep       Date:  2020 Jan-Dec

5.  Prevalence of Hypothyroidism in Patients With Erdheim-Chester Disease.

Authors:  Skand Shekhar; Ninet Sinaii; Jorge A Irizarry-Caro; William A Gahl; Juvianee I Estrada-Veras; Rahul Dave; Georgios Z Papadakis; Amit Tirosh; Brent S Abel; Joanna Klubo-Gwiezdzinska; Monica C Skarulis; Bernadette R Gochuico; Kevin O'Brien; Fady Hannah-Shmouni
Journal:  JAMA Netw Open       Date:  2020-10-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.